Global Genital Warts Market
Healthcare Services

What’s The Growth Forecast For Genital Warts Market Through 2024-2033?

The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

The genital warts market has shown robust growth over the past few years, driven by a variety of factors such as increasing awareness, advances in treatment options, and growing clinical trials. Here’s a detailed overview of the market’s current state, growth prospects, and key trends.

Strong Market Growth

  • The genital warts market grew from $1.87 billion in 2023 to $1.97 billion in 2024, representing a compound annual growth rate (CAGR) of 5.4%.
  • Growth has been fueled by a focus on patient-centered care, increased emphasis on early detection and treatment, and the growing availability of self-targeted therapies.
  • The rising recurrence of genital warts has also driven the market’s expansion.

Future Growth Forecast

  • The market is expected to grow to $2.44 billion by 2028, with a CAGR of 5.5%.
  • Factors contributing to this growth include the adoption of telemedicine and digital health platforms for remote consultation and treatment monitoring.
  • Increasing demand for affordable treatments for sexually transmitted infections (STIs) and innovative procedures like loop electrosurgical excision are also key drivers.

View More On The Genital Warts Market Report 2024 – https://www.thebusinessresearchcompany.com/report/genital-warts-global-market-report

Key Trends Shaping the Market

  • The shift towards combination therapies and advancements in diagnostic technologies are emerging trends in the market.
  • Expansion of telehealth and online consultations allows for more accessible treatment, especially in remote areas.
  • Emerging markets are expected to see significant growth, providing a wider global footprint for genital warts treatments.

Rising STI Rates Driving Market Growth

  • The increasing prevalence of sexually transmitted infections (STIs) is a major factor driving the genital warts market forward.
  • Genital warts, caused by certain strains of the human papillomavirus (HPV), spread through skin-to-skin contact during sexual activity.
  • STI rates are rising globally, partly due to increased sexual activity, inadequate use of protection, and limited access to healthcare. For example, HIV cases increased from 38.7 million in 2021 to 39.0 million in 2022.

Major Players in the Genital Warts Market

  • Key companies include Merck & Co. Inc., AbbVie Inc, Sanofi S.A, Novartis AG, and 3M Company.
  • Other significant players include Bausch Health Companies Inc, Sun Pharmaceuticals, and Verrica Pharmaceuticals Inc.
  • These companies are focused on developing innovative treatments to improve patient outcomes and reduce recurrence rates.

Innovative Dermatology Drugs

  • Innovation is a key trend, with companies developing new dermatology drugs specifically for genital warts.
  • For instance, Verrica Pharmaceuticals received New Chemical Entity (NCE) status from the FDA for YCANTH, a drug candidate for genital warts.
  • The NCE status grants Verrica at least five years of protection from generic competition, encouraging further investment in new treatments.

Partnerships and Collaborations Boost Market Growth

  • In March 2021, Verrica Pharmaceuticals partnered with Torii Pharmaceutical Co. Ltd. to commercialize YCANTH in Japan for treating genital warts.
  • Such partnerships enhance the development and availability of novel treatments across different markets, accelerating market growth.

Regional Outlook

  • North America was the largest region in the genital warts market in 2023, driven by advanced healthcare systems and widespread access to treatment.
  • However, Asia-Pacific is expected to be the fastest-growing region due to increased healthcare investments and improving healthcare infrastructure.

The genital warts market is on a solid growth trajectory, driven by rising STI rates, innovations in treatment options, and the expanding use of telehealth. As the market continues to evolve, key players are expected to focus on developing affordable, effective, and accessible treatments to meet the growing demand worldwide.

Request A Sample Of The Global Genital Warts Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=18374&type=smp